The development and implementation of a rapid-access long-acting injectable buprenorphine clinic in metropolitan Melbourne during the COVID-19 pandemic.

Straub, Adam; Pastor, Adam; Lloyd-Jones, Martyn; O'Neill, Helen; Bonomo, Yvonne

Straub, Adam; Pastor, Adam; Lloyd-Jones, Martyn; O'Neill, Helen; Bonomo, Yvonne.

Straub A; Department of Addiction Medicine, St. Vincent's Hospital Melbourne, Melbourne, Australia.
Pastor A; Department of Addiction Medicine, St. Vincent's Hospital Melbourne, Melbourne, Australia.
Lloyd-Jones M; Department of Addiction Medicine, St. Vincent's Hospital Melbourne, Melbourne, Australia.
O'Neill H; Department of Addiction Medicine, St. Vincent's Hospital Melbourne, Melbourne, Australia.
Bonomo Y; Department of Addiction Medicine, St. Vincent's Hospital Melbourne, Melbourne, Australia.

Drug Alcohol Rev ; 40(4): 681-682, 2021 05.

Article in English | MEDLINE | ID: covidwho-751764

Subject(s)

Ambulatory Care Facilities/trends; Buprenorphine/administration & dosage; COVID-19/epidemiology; Narcotic Antagonists/administration & dosage; Opiate Substitution Treatment/trends; Opioid-Related Disorders/drug therapy; Delayed-Action Preparations/administration & dosage; Humans; Opiate Substitution Treatment/methods; Opioid-Related Disorders/epidemiology; Victoria/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Buprenorphine / Opiate Substitution Treatment / Ambulatory Care Facilities / COVID-19 / Narcotic Antagonists / Opioid-Related Disorders Type of study: Observational study Topics: Long Covid Limits: Humans Country/Region as subject: Oceania Language: English Journal: Drug Alcohol Rev Journal subject: Substance-Related Disorders Year: 2021 Document Type: Article Affiliation country: Dar.13161

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google